JP Morgan Chase
MDWD icon

JP Morgan Chase’s MediWound MDWD Stock Holding History

JP Morgan Chase’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
4,237
+266
+7% +$4.22K ﹤0.01% 6318
2026
Q1 		$61.4K Sell
3,971
-42
-1% -$731 ﹤0.01% 6107
2025
Q4 		$74.1K Buy
4,013
+830
+26% +$15.2K ﹤0.01% 6050
2025
Q3 		$57.4K Sell
3,183
-707
-18% -$13K ﹤0.01% 6180
2025
Q2 		$75.3K Sell
3,890
-635
-14% -$12K ﹤0.01% 5733
2025
Q1 		$70.2K Buy
4,525
+957
+27% +$17.1K ﹤0.01% 5744
2024
Q4 		$63.5K Buy
3,568
+167
+5% +$2.88K ﹤0.01% 5923
2024
Q3 		$61.4K Sell
3,401
-75,360
-96% -$1.38M ﹤0.01% 5917
2024
Q2 		$1.22M Buy
78,761
+5,424
+7% +$89.7K ﹤0.01% 4142
2024
Q1 		$1.05M Buy
73,337
+73,330
+1,047,571% +$1M ﹤0.01% 4322
2023
Q4 		$71 Buy
+7
New +$63 ﹤0.01% 7159
2023
Q1 		– Sell
-2
Closed – – 7027
2022
Q4 		$0 Buy
+2
New +$20 ﹤0.01% 6814
2022
Q2 		– Sell
-424
Closed -$6K – 6711
2022
Q1 		$6K Sell
424
-3,639
-90% -$59K ﹤0.01% 6291
2021
Q4 		$67K Sell
4,063
-8,872
-69% -$185K ﹤0.01% 5841
2021
Q3 		$301K Buy
12,935
+3,423
+36% +$91.4K ﹤0.01% 5014
2021
Q2 		$255K Buy
9,512
+3,070
+48% +$94.9K ﹤0.01% 5103
2021
Q1 		$242K Buy
+6,442
New +$233K ﹤0.01% 5071
2019
Q3 		– Sell
-5,139
Closed -$123K – 5865
2019
Q2 		$123K Sell
5,139
-7,260
-59% -$224K ﹤0.01% 4855
2019
Q1 		$434K Buy
+12,399
New +$417K ﹤0.01% 4277
2018
Q4 		– Sell
-2,349
Closed -$101K – 5821
2018
Q3 		$101K Buy
2,349
+316
+16% +$14.2K ﹤0.01% 4949
2018
Q2 		$98K Buy
2,033
+1,990
+4,628% +$85.7K ﹤0.01% 4842
2018
Q1 		$2K Buy
+43
New +$1.35K ﹤0.01% 5286

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's MDWD Position: Q2 2026 in Review

JP Morgan Chase increased its MediWound (MDWD) stake by 6.7% in Q2 2026, buying an estimated $4.22K and bringing the position to 4,237 shares worth $63.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6318.

JP Morgan Chase first reported a position in MDWD in Q1 2018 and has held it in 22 quarters since. The position peaked at $1.22M in Q2 2024. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • JP Morgan Chase held 4,237 shares of MediWound worth $63.9K as of Q2 2026.
  • JP Morgan Chase bought 266 MediWound shares in Q2 2026, an estimated $4.22K.
  • MediWound made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6318 holding.
  • JP Morgan Chase first reported a position in MediWound in Q1 2018 and has held it in 22 quarters since.
  • JP Morgan Chase's MediWound position peaked at $1.22M in Q2 2024.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.